Market Place
Sourcing Support
FDA Grants Orphan Drug Status To Biostar Pharma`s Utidelone
25 Sep 2025 //
PR NEWSWIRE
Biostar Achieves 1st Patient Dosing in Two Ph II/III UTD2 Trials
15 Sep 2025 //
PR NEWSWIRE
Novotech & Biostar Form Strategic Partnership After HKEX Listing
12 Nov 2024 //
BUSINESSWIRE
Biostar Completes Patient Recruitment for US Phase 1 Utidelone Study
03 Sep 2024 //
PR NEWSWIRE
Biostar Pharma`s UTD1 IND Cleared For Phase 2 In HER2- Breast Cancer Metastasis
05 Jul 2024 //
PR NEWSWIRE
FDA Granted ODD to Utidelone Injectable from Biostar Pharma f
01 Apr 2024 //
INDIANPHARMAPOST
FDA Granted ODD to Utidelone Injectable from Biostar for the Breast Cancer
29 Mar 2024 //
PR NEWSWIRE
100% CBR! FDA Granted ODD to Biostar Pharma UTD2 for the Gastric Cancer
21 Mar 2024 //
PR NEWSWIRE
Biostar announces first patient enrolled for Phase 1 study of Utidelone Capsule
13 Jun 2023 //
INDIAN PHARMA PSOT
Biostar Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule
12 Jun 2023 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.